Two million euros for XO Life's patient insights platform

The medtech start-up XO Life, based in Berlin and Munich, raised more than 2 million euros to further develop its patient insights platform for drugs and therapies, which the company has developed from a leading reporting and information platform for side effects. The patient insights platform enables patients to record their own experiences with their health status, medications and illnesses, so-called patient-reported outcomes (PRO), in a standardized and privacy-compliant manner. The experiences can be compared with other users and transmitted anonymously to the healthcare industry to further develop their products and improve their therapies.